Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lappaconitine Adhesive Patch for Oral Mucositis Pain in Nasopharyngeal Cancer
NCT03518489Unknown
- Sponsor
- Fujian Medical University Cancer Hospital
- Start
- Jul 2018
- Primary completion
- Dec 2018
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of lappaconitine in oral mucositis (OM) (2 arms), sponsored by Fujian Medical University Cancer Hospital. Primary endpoint: Numeric Rating Scale for Pain at 7 weeks. Status: unknown.
02
Drugs
lappaconitine
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT03518489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03518489.